LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.

Saved in:
Bibliographic Details
Title: LySeqST: a targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma.
Authors: Hilton LK; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada., Gillis S; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Y-Moayyed F; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Bridgers J; Department of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada., Alduaij W; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Jiang A; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Collinge B; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Wong JCH; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Boyle M; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Meissner B; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada., Slack GW; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Farinha P; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Craig JW; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada.; Department of Pathology, University of Virginia Health, Charlottesville, VA., Gerrie AS; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Villa D; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Savage KJ; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Sehn LH; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Karsan A; Department of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Wright GW; Biometric Research Branch, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD., Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Morin RD; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.; Department of Basic and Translational Research, BC Cancer Research Institute, Vancouver, BC, Canada., Steidl C; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer Research Institute, Vancouver, BC, Canada.; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Source: Blood advances [Blood Adv] 2026 Jun 23; Vol. 10 (12), pp. 4208-4214.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2026020105